Patent · US Active

Compounds

US11919856B2 · kind B2 · utility

0Cited by
3References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2022
Grant dateMar 5, 2024
Priority date
Expiry dateJun 23, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, for example as modulators of alpha I antitrypsin and treating diseases associated with alpha antitrypsin, particularly liver diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.